About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT01720758

Assessment of the V600E Mutation in the B-RAF Gene in Chronic Lymphoproliferative Disease

The presence of a specific mutation in the gene known as B-RAF has been found in patients who have Hairy Cell Leukemia. In this study this specific mutation known as V600E will be ascertained in perip...

Lead sponsor: HaEmek Medical Center, Israel•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

HaEmek Medical Center, Israel

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Patients over the age of 18 years -

Exclusion Criteria

•Patients less than 18 years in age or mentally defectives.
•\-

Related studies

RECRUITINGPhase 2

Venetoclax for the Treatment of Patients With Relapsed Hairy Cell Leukemia

NCT06311227 · Recurrent Hairy Cell Leukemia, Recurrent Hairy Cell Leukemia Variant

RECRUITINGPhase 2

Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

NCT00412594 · Hairy Cell Leukemia, Recurrent Hairy Cell Leukemia

RECRUITINGPhase 1

Phase I Study of Anti-CD22 Chimeric Receptor T Cells in Patients With Relapsed/Refractory Hairy Cell Leukemia and Variant

NCT04815356 · Hairy Cell Leukemia, Hairy Cell Leukemia Variant

RECRUITINGPhase 2

Epcoritamab in Patients With Newly Diagnosed Marginal Zone Lymphoma (MZL)

NCT06796998 · Marginal Zone Lymphoma, Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue, and more

RECRUITINGPhase 1

AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas

NCT06340737 · Follicular Lymphoma, Mantle Cell Lymphoma, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 11, 2017Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment20

Start dateNov 2012

Last updatedAug 11, 2017

Condition

Hairy Cell Leukemia Splenic Marginal Zone Lymphoma

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 11, 2017Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions